Lavo

Lavo Life Sciences provides an AI-accelerated solution for predicting the crystal structures of small molecule medications. This advanced tool is primarily used to assist and expedite medication development by forecasting the crystal structure of drugs in their molecular form.

This AI tool enhances solid-state formulations and mitigates pipeline risks by preventing unexpected issues late in the development cycle. With a team of chemists and engineers, Lavo Life Sciences integrates AI with expertise in computational chemistry to deliver cutting-edge solutions for pharmaceutical development teams.

This tool aims to decrease the likelihood of unexpected crystal forms affecting development, shorten the time needed to identify crystal forms, and improve drug formulations for better stability and easier manufacturing.

It also uniquely enables the discovery of new polymorphs that offer enhanced characteristics. Primarily, Lavo Life Sciences seeks to streamline the medication development process through inventive AI-powered solutions.